Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateQ/C Technologies, Inc. Common Stock
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
Flagged at $1.10 at 11:36 AM on Sep 16, then ran to $2.16 +95% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is QCLS down today? It is at $0.620 (-2.61%), and our scanner flagged it 190 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment QCLS spikes, and full due diligence on QCLS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $QCLS 190 times in the last 30 days. Create a free account to track $QCLS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on QCLS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for QCLS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Silverman Joshua Officer | Acquired (grant/award) | +77K 0.9% of company | added 58% | 211K | n/a | Oct 1, 26 |
Silverman Joshua Officer | Acquired (grant/award) | +17K 0.2% of company | added 14% | 133K | n/a | Jul 10, 26 |
Silverman Joshua Officer | Acquired (grant/award) | +162K 2.0% of company | added 100% | 262K | n/a | Apr 13, 26 |
Voss Chelsea Sierra Director | Bought (open market) | +2K 0.02% of company | added 2.9% | 62K | $6K at $3.15 | Mar 30, 26 |
Voss Chelsea Sierra Director | Acquired (grant/award) | +238K 2.9% of company | added 100% | 240K | n/a | Jan 16, 26 |
Rauch Gary M Other | Acquired (grant/award) | +11K 0.1% of company | added 100% | 13K | n/a | Nov 14, 25 |
Bernstein Bruce Director | Acquired (grant/award) | +25K 0.3% of company | n/a | 25K | n/a | Nov 14, 25 |
Friscia Stephen Director | Acquired (grant/award) | +23K 0.3% of company | added 100% | 25K | n/a | Nov 14, 25 |
Silverman Joshua Officer | Acquired (grant/award) | +91K 1.1% of company | added 100% | 100K | n/a | Nov 14, 25 |
Glass Mitchell Officer | Acquired (grant/award) | +11K 0.1% of company | added 100% | 13K | n/a | Nov 14, 25 |
White Billy Joe Director | Acquired (grant/award) | +23K 0.3% of company | added 100% | 25K | n/a | Nov 14, 25 |
Rauch Gary M Other | Acquired (grant/award) | +1K 0.01% of company | n/a | 1K | n/a | Oct 3, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in in vitro & in vivo diagnostic substances, closest in size first.
Here is the latest on QCLS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for QCLS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
QCLS last traded at $0.620, down 2.61% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Q/C Technologies, Inc. Common Stock (QCLS) is next expected to report earnings on Wednesday, November 18, 2026, about 41 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The QCLS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged QCLS 190 times in the last 30 days.
QCLS (Q/C Technologies, Inc. Common Stock) trades on XNAS, with a market cap of about $5M in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge QCLS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$QCLS discussion
Sign in to ask a question or join the discussion.